Delivery Order SPE2DB24D6041-SPE2DB25FKCJG
- Not listed
- The Defense Logistics Agency awarded a $3,007.12 delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Zymfentra 120 mg/ml pen (2-pack units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of August 21, 2025. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,503.56 to AmerisourceBergen Drug Corp for Zymfentra 120 mg/mL pen (2-pack) pharmaceutical supplies. This firm fixed-price delivery order, issued on July 31, 2025, with an ultimate completion date of August 21, 2025, represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract issued under a larger indefinite...
- This delivery order, awarded on July 31, 2025, to AmerisourceBergen Drug Corp under contract number 4568952013, procures Zymfentra 120 mg/ml pen (2-pack) units with a ceiling value of $1,503.56. The contract represents a competitive, non-set-aside award issued under firm fixed price terms, with an ultimate completion date of August 21, 2025. AmerisourceBergen's Corporate Office division, headquartered in Conshohocken, Pennsylvania, serves as the place of performance and fulfillment point for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,503.56 on July 24, 2025, for Zymfentra 120 mg/ml pens (2-packs), with an ultimate completion date of August 14, 2025. This non-set-aside contract utilizes firm fixed pricing and represents performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $3,007.12 for Zymfentra 120 mg/ml pens (2-pack quantity) on August 1, 2025, with an ultimate completion date of August 22, 2025. The contract is structured as a firm fixed price delivery order with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the place of performance location. This delivery order...
- This delivery order, valued at $3,007.12 and awarded July 21, 2025, by the Defense Logistics Agency, provides Zymfentra 120 mg/ml pens (2-pack quantity) to support federal medical supply needs. The contract is a firm fixed price delivery order with no set-aside designation, awarded competitively to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. Performance will be completed by August 11, 2025, at the contractor's facility in...
- The U.S. Defense Department's Medical Supply Chain awarded a $3,007.12 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zymfentra 120 mg/mL pen kits, with an ultimate completion date of August 25, 2025. This non-set-aside competitive award was issued on August 4, 2025, and will be performed at the contractor's Conshohocken, Pennsylvania facility. As a child order under a larger contract vehicle, this delivery order represents a routine pharmaceutical procurement supporting...
- The Defense Logistics Agency awarded a $26,548.41 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Zepbound 2.5 mg/0.5 mL pens. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of July 29, 2025, and will be performed at the vendor's facility in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to meet federal...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of ZYMFENTRA 120 MG/ML PEN (2PK)S. The firm-fixed-price contract, valued at $3,007.12, has an ultimate completion date of August 1, 2025. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle for military...
- The Defense Logistics Agency awarded a delivery order valued at $3,050.40 to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pens. This is a firm fixed price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of August 4, 2025. The order will be fulfilled from AmerisourceBergen's location in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order represents a...
- SPE2DB24D6041Indefinite Delivery Contract
- SPE2DB24D6041-SPE2DB25FKCJGDelivery Order
The Defense Logistics Agency awarded a $2,106.45 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Zymfentra 120 mg/ml pen (2-pack units). This is a firm fixed price delivery order with an ultimate completion date of August 18, 2025, and represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement valued through December 2026 that serves as a comprehensive pharmaceutical support vehicle for military healthcare systems worldwide. The IDC enables AmerisourceBergen to supply a broad range of pharmaceutical products, medical supplies, vaccines, and specialty medications across multiple therapeutic domains to support Defense Health Agency and other federal healthcare customers globally. The current delivery order represents a routine execution of this strategic pharmaceutical supply relationship.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 7/28/25 |